<DOC>
	<DOC>NCT02746666</DOC>
	<brief_summary>The purpose of this study is to investigate the impact of pharmacist behavioral intervention's influence on breast cancer patients' quality of life. Croatian randomized controlled trial. Targeted population: general population of breast cancer patients under the first adjuvant anthracycline chemotherapy. Primary outcome: difference in EORTC QLQ-BR23 questionnaire result from the baseline to after 3 week cycle.</brief_summary>
	<brief_title>Pharmacist's Influence on Breast Cancer Patient Quality of Life</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Early breast cancer First adjuvant chemotherapy Chemotherapy protocol: anthracycline x 4 Cardiovascular comorbidities Regular nausea or vomiting during six months before enrollment Unable to answer the quality of life questionnaire on their own</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>